Category: Active Surveillance

“Halt! Who goes there?” The world of Hollywood is filled with movies in which an alert sentry confronts a sneaky intruder. No matter which era is depicted—the Middle Ages, the Wild West, World War II—the watchful guardians are spaced out at various points along a castle parapet, a fort’s watch towers, or a defensive line. keep reading

We’ve all heard the saying that no news is good news. It’s meant to be reassuring in the face of worry over an unknown outcome. The news must not be bad, because you would have heard if it were. When it comes to using multiparametric MRI (mpMRI) for Active Surveillance (AS) monitoring, a negative scan keep reading

“…any energy source can be applied to the super-active surveillance concept allowing more men to consider a tissue-preserving therapy for prostate cancer.” – Corradi et al. 2019[i] Thanks to a growing recognition among professionals that clinically insignificant PCa may never become life-threatening, a larger percentage of low-risk PCa patients are starting their treatment journey with keep reading

These days, Active Surveillance (AS) seems to be the new best friend for prostate cancer (PCa) patients. Over 40% of newly diagnosed, low-to-favorable intermediate risk patients now begin PCa management on AS. This method defers treatment, but there’s a catch. Patients must be responsible to: Obtain the most thorough portrait of your PCa (multiparametric MRI, keep reading

“It has been suggested by some investigators that a negative or stable MRI could replace the surveillance biopsy in men on AS.” – Dr. Badar Mian With apologies to Ralph Waldo Emerson for paraphrasing a famous saying attributed to him: Build a better prostate biopsy and the urological world will beat a path to your keep reading

I just read a terrific blog by a Chicago author, Howard Wolinsky, who has been on Active Surveillance for Wilensky 10 years. He has Gleason 3+3 prostate cancer—and is doing just fine! As he reflects on his own experience, he quotes from several experts in urologic surgery and clinical pathology. Spoiler alert: he articulates both keep reading

The average male human heart is slightly less than a half percent of total body weight, and it weighs about ten times more than the same man’s prostate gland. Most people would likely agree that the heart is at least ten times more important than the prostate. However, I suspect that the average man thinks keep reading

At first glance, the title question appears to have a self-evident answer. Everyone knows that a good workout program that includes at least 150 minutes of aerobic exercise is advantageous for the body’s cardiovascular system. This increases the chance of a long life in good health. And of course, we’re all aware that aerobic fitness keep reading

Who is the world’s leading prostate cancer expert? How does one even begin to answer that question? There are so many great minds dealing with prostate cancer from so many angles: biology, urology, radiology, oncology, pathology and more—it’s impossible to identify a single authority on the subject. However, when great minds work together, powerful consensus keep reading

In recent years, there’s been a huge groundswell of Active Surveillance (AS) for low-risk prostate cancer (PCa) patients. In fact, it’s considered the preferred PCa management strategy for men with lower-risk disease. There are two primary factors at play: 1) patient resistance to undergoing definitive whole gland treatments that can impair urinary and sexual function, keep reading